Telaprevir Experience From Turkey

BACKGROUND: In patients with chronic hepatitis C, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genot...

詳細記述

保存先:
書誌詳細
出版年:Hepat Mon
主要な著者: Komur, Suheyla, Kurtaran, Behice, Inal, Ayse Seza, Pullukcu, Husnu, Ulu, Aslihan, Kuscu, Ferit, Yamazhan, Tansu, Tasova, Yesim, Aksu, Hasan Salih Zeki
フォーマット: Artigo
言語:Inglês
出版事項: Kowsar 2015
主題:
Brief Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350246/
https://ncbi.nlm.nih.gov/pubmed/25788959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.25639
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料